Detalhe da pesquisa
1.
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Immunity
; 54(8): 1869-1882.e6, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270939
2.
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
Nature
; 603(7902): 687-692, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062015
3.
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters.
PLoS Pathog
; 20(1): e1011805, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198521
4.
Plitidepsin as an Immunomodulator against Respiratory Viral Infections.
J Immunol
; 212(8): 1307-1318, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416036
5.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
6.
Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity.
Small
; 20(10): e2306892, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867244
7.
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
N Engl J Med
; 383(16): 1544-1555, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722908
8.
Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient.
J Infect Dis
; 226(2): 258-269, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429403
9.
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections.
J Leukoc Biol
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289826
10.
Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586014
11.
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia.
Front Immunol
; 14: 1217181, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600776
12.
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters.
bioRxiv
; 2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425792
13.
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.
Sci Transl Med
; 14(676): eade0424, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542692
14.
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
Sci Transl Med
; 14(650): eabo5032, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731888
15.
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.
Front Immunol
; 12: 772864, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34956199
16.
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Lancet Respir Med
; 9(10): 1111-1120, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864736
17.
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
Science
; 373(6556)2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210892
18.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants.
bioRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655252
19.
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.
Cell Rep
; 33(4): 108322, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091382
20.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.
bioRxiv
; 2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577634